Hancock Whitney Corp purchased a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 14,818 shares of the biopharmaceutical company’s stock, valued at approximately $275,000. Several other large investors have also recently […]